These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 17576401

  • 1. [Antiphospholipid antibodies and recurrent abortions: possible pathogenetic role of annexin A5 investigated by confocal microscopy].
    Peluso G, Morrone G.
    Minerva Ginecol; 2007 Jun; 59(3):223-9. PubMed ID: 17576401
    [Abstract] [Full Text] [Related]

  • 2. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.
    Rand JH, Wu XX, Quinn AS, Taatjes DJ.
    Lupus; 2010 Apr; 19(4):460-9. PubMed ID: 20353989
    [Abstract] [Full Text] [Related]

  • 3. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.
    Rand JH, Wu XX, Andree HA, Lockwood CJ, Guller S, Scher J, Harpel PC.
    N Engl J Med; 1997 Jul 17; 337(3):154-60. PubMed ID: 9219701
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antibodies against annexin A5: detection pitfalls and clinical associations.
    Bozic B, Irman S, Gaspersic N, Kveder T, Rozman B.
    Autoimmunity; 2005 Sep 17; 38(6):425-30. PubMed ID: 16278147
    [Abstract] [Full Text] [Related]

  • 8. The use of atomic force microscopy to study the pathologic effects of anti-annexin autoantibodies.
    Irman S, Skarabot M, Muševič I, Rozman B, Božič B.
    J Autoimmun; 2011 Mar 17; 36(2):98-105. PubMed ID: 21185149
    [Abstract] [Full Text] [Related]

  • 9. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.
    Rand JH, Wu XX, Quinn AS, Chen PP, McCrae KR, Bovill EG, Taatjes DJ.
    Am J Pathol; 2003 Sep 17; 163(3):1193-200. PubMed ID: 12937161
    [Abstract] [Full Text] [Related]

  • 10. Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes.
    Wolgast LR, Arslan AA, Wu XX, Beyda JN, Pengo V, Rand JH.
    J Thromb Haemost; 2017 Jul 17; 15(7):1412-1421. PubMed ID: 28393472
    [Abstract] [Full Text] [Related]

  • 11. Antibody-mediated interference with annexins in the antiphospholipid syndrome.
    Rand JH, Wu XX.
    Thromb Res; 2004 Jul 17; 114(5-6):383-9. PubMed ID: 15507268
    [Abstract] [Full Text] [Related]

  • 12. Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome.
    Bećarević M, Sarić M, Stojanovich L, Mirković D, Dopsaj V, Ignjatović S.
    Clin Rheumatol; 2018 Dec 17; 37(12):3359-3364. PubMed ID: 29948348
    [Abstract] [Full Text] [Related]

  • 13. Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome.
    Rand JH, Wu XX, Quinn AS, Taatjes DJ.
    Lupus; 2008 Oct 17; 17(10):922-30. PubMed ID: 18827057
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to beta2-glycoprotein I and annexin V in women with early and late idiopathic recurrent spontaneous abortions.
    Zammiti W, Mtiraoui N, Hidar S, Fekih M, Almawi WY, Mahjoub T.
    Arch Gynecol Obstet; 2006 Aug 17; 274(5):261-5. PubMed ID: 16826414
    [Abstract] [Full Text] [Related]

  • 15. Oxidized LDL, anti-oxidized LDL and anti-annexin A5 antibodies in primary antiphospholipid syndrome.
    Becarevic M, Singh S, Majkic-Singh N.
    Clin Lab; 2008 Aug 17; 54(3-4):97-101. PubMed ID: 18630740
    [Abstract] [Full Text] [Related]

  • 16. A comprehensive screening analysis of antiphospholipid antibodies in Indian women with fetal loss.
    Vora S, Shetty S, Salvi V, Satoskar P, Ghosh K.
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr 17; 137(2):136-40. PubMed ID: 17644242
    [Abstract] [Full Text] [Related]

  • 17. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML, Hughes GR, Khamashta MA.
    Clin Lab; 2004 Apr 17; 50(11-12):653-65. PubMed ID: 15575307
    [Abstract] [Full Text] [Related]

  • 18. Effects of anti-cardiolipin antibodies and IVIg on annexin A5 binding to endothelial cells: implications for cardiovascular disease.
    Frostegård AG, Su J, von Landenberg P, Frostegård J.
    Scand J Rheumatol; 2010 Apr 17; 39(1):77-83. PubMed ID: 20132075
    [Abstract] [Full Text] [Related]

  • 19. Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome.
    de Laat B, Derksen RH, Mackie IJ, Roest M, Schoormans S, Woodhams BJ, de Groot PG, van Heerde WL.
    Ann Rheum Dis; 2006 Nov 17; 65(11):1468-72. PubMed ID: 16449315
    [Abstract] [Full Text] [Related]

  • 20. Antiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome.
    Pelusa HF, Pezzarini E, Basiglio CL, Musuruana J, Bearzotti M, Svetaz MJ, Daniele SM, Bottai H, Arriaga SM.
    Ann Clin Biochem; 2017 Sep 17; 54(5):577-583. PubMed ID: 27638930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.